Crystallographic Study of a Novel Sub-Nanomolar Inhibitor Provides Insight on the Binding Interactions of Alkenyldiarylmethanes with Human Immunodeficiency Virus-1 (HIV-1) Reverse Transcriptase

Documenti analoghi

• Investigation of the Alkenyldiarylmethane Non-nucleoside Reverse Transcriptase Inhibitors as Potential cAMP Phosphodiesterase-4B2 Inhibitors
  di: Cullen, Matthew D., et al.
  Pubblicazione: (2007)
• Inhibition of Tubulin Polymerization by Select Alkenyldiarylmethanes
  di: Cullen, Matthew D., et al.
  Pubblicazione: (2007)
• Synthesis and Anti-HIV Activity of New Metabolically Stable Alkenyldiarylmethane (ADAM) Non-Nucleoside Reverse Transcriptase Inhibitors (NNRTIs) Incorporating N-Methoxy Imidoyl Halide and 1,2,4-Oxadiazole Systems
  di: Sakamoto, Takeshi, et al.
  Pubblicazione: (2007)
• Synthesis, Anti-HIV Activity, and Metabolic Stability of New Alkenyldiarylmethane (ADAM) HIV-1 Non-Nucleoside Reverse Transcriptase Inhibitors (NNRTIs)
  di: Deng, Bo-Liang, et al.
  Pubblicazione: (2005)
• Synthesis of alkenyldiarylmethanes (ADAMs) containing benzo[d]isoxazole and oxazolidin-2-one rings, a new series of potent non-nucleoside HIV-1 reverse transcriptase inhibitors
  di: Deng, Bo-Liang, et al.
  Pubblicazione: (2008)